Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response of the Urothelial Carcinoma Cell Lines to Cisplatin.
Holíčková A, Roška J, Órásová E, Bruderová V, Palacka P, Jurkovičová D, Chovanec M. Holíčková A, et al. Among authors: palacka p. Int J Mol Sci. 2022 Oct 18;23(20):12488. doi: 10.3390/ijms232012488. Int J Mol Sci. 2022. PMID: 36293346 Free PMC article.
The first cancer patient with COVID-19 in Slovakia.
Slopovský J, Šálek T, Pazderová N, Zomborská E, Makovník M, Palacka P, Horniczká K, Stankovič I, Pörsök Š. Slopovský J, et al. Among authors: palacka p. Klin Onkol. 2020 Spring;33(5):386-389. doi: 10.14735/amko2020386. Klin Onkol. 2020. PMID: 33108884 English.
The prognostic value of DNA damage level in peripheral blood lymphocytes of chemotherapy-naïve patients with germ cell cancer.
Sestakova Z, Kalavska K, Hurbanova L, Jurkovicova D, Gursky J, Chovanec M, Svetlovska D, Miskovska V, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Cingelova S, Spanik S, Mardiak J, Chovanec M, Mego M. Sestakova Z, et al. Among authors: palacka p. Oncotarget. 2016 Nov 15;7(46):75996-76005. doi: 10.18632/oncotarget.12515. Oncotarget. 2016. PMID: 27732956 Free PMC article.
Phase II study of avelumab in multiple relapsed/refractory germ cell cancer.
Mego M, Svetlovska D, Chovanec M, Rečkova M, Rejlekova K, Obertova J, Palacka P, Sycova-Mila Z, De Giorgi U, Mardiak J. Mego M, et al. Among authors: palacka p. Invest New Drugs. 2019 Aug;37(4):748-754. doi: 10.1007/s10637-019-00805-4. Epub 2019 Jun 1. Invest New Drugs. 2019. PMID: 31152292 Clinical Trial.
High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy.
Hapakova N, Sestakova Z, Holickova A, Hurbanova L, Miskovska V, Chovanec M, Rejlekova K, Svetlovska D, Kalavska K, Obertova J, Palacka P, Sycova-Mila Z, Mardiak J, Chovanec M, Mego M. Hapakova N, et al. Among authors: palacka p. Clin Genitourin Cancer. 2019 Oct;17(5):e1020-e1025. doi: 10.1016/j.clgc.2019.06.004. Epub 2019 Jun 13. Clin Genitourin Cancer. 2019. PMID: 31281064
DNA damage measured in blood cells predicts overall and progression-free survival in germ cell tumour patients.
Sestakova Z, Kalavska K, Smolkova B, Miskovska V, Rejlekova K, Sycova-Mila Z, Palacka P, Obertova J, Holickova A, Hurbanova L, Jurkovicova D, Roska J, Goffa E, Svetlovska D, Chovanec M, Mardiak J, Mego M, Chovanec M. Sestakova Z, et al. Among authors: palacka p. Mutat Res Genet Toxicol Environ Mutagen. 2020 Jun-Jul;854-855:503200. doi: 10.1016/j.mrgentox.2020.503200. Epub 2020 May 23. Mutat Res Genet Toxicol Environ Mutagen. 2020. PMID: 32660824
47 results